Real-World Use of Once-Weekly Semaglutide in Thai Patients With Type 2 Diabetes Mellitus in a Private Hospital Setting

OBJECTIVE: To evaluate the real-world use of once-weekly semaglutide among Thai patients with type 2 diabetes (T2DM) in a private hospital setting. METHODOLOGY: A retrospective review of Thai patients with T2DM who have initiated semaglutide for at least 1 month between June 2020 and March 2022 at T...

Descripción completa

Detalles Bibliográficos
Autores principales: Thewjitcharoen, Yotsapon, Yenseung, Nalin, Butadej, Siriwan, Nakasatien, Soontaree, Chotwanvirat, Phawinpon, Chatchomchuan, Waralee, Wanothayaroj, Ekgaluck, Krittiyawong, Sirinate, Himathongkam, Thep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the ASEAN Federation of Endocrine Societies 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213164/
https://www.ncbi.nlm.nih.gov/pubmed/37252413
http://dx.doi.org/10.15605/jafes.038.01.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213164/
https://www.ncbi.nlm.nih.gov/pubmed/37252413
http://dx.doi.org/10.15605/jafes.038.01.11

Ejemplares similares